Determinations that Products were Not Withdrawn from Sale for Reasons of Safety or Effectiveness: GEREF (Sermorelin Acetate) Injection, 0.5 Milligrams Base/Vial and 1.0 Milligrams Base/Vial, and GEREF (Sermorelin Acetate) Injection, 0.05 Milligrams Base/Amp

Document ID: FDA-2012-P-1071-0003
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2013-04827
View Document:  View as format pdf View as format html

Details Information

Document Subtype: General Notice
Received Date: March 04 2013, at 12:00 AM Eastern Standard Time
Start-End Page: 14095 - 14096
Page Count: 2
Comment Start Date: March 4 2013, at 12:00 AM Eastern Standard Time

Comments

Total: 0
No comments posted.

Related Documents

Total: 0
No documents available.